5 most significant publications

1. Juarez, V,  Pasolli, H A, Hellwig, A,Garbi, N and Cid Arregui, A. Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic Mice. 2012. Open Virol J, Vol. 6:270-276.

2. Garcia-Chagollan M, Jave-Suarez LF, Haramati J, Sanchez-Hernandez PE, Aguilar-Lemarroy A, Bueno-Topete MR, Pereira-Suarez AL, Fafutis-Morris M, Cid-Arregui A, del Toro-Arreola S. Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1. J Biomed Sci. 2013 Aug 16;20:60.

3. Darnell, G.A., Schroder, W.S., Antalis, T.M., Lambley, E., Major, L., Gardner, J., Birrell, G.,  Cid-Arregui, A. and Suhrbier A. (2007) The accelerated degradation of the retinoblastoma protein mediated by human papillomavirus E7 requires the cysteine protease calpain. J BIol Chem 282:37492-37500.

4. Baez-Astua, A., E. Herraez-Hernandez, N. Garbi, H. A. Pasolli, V. Juarez, H. Zur Hausen, and A. Cid-Arregui (2005). Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 e7 proteins induces enhanced e7-specific antibody and cytotoxic T-cell responses J Virol. 79:12807-17.

5. Cid-Arregui, A., Juarez, V. and zur Hausen, H. (2003) A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol. 77:4928-37.

to top